FALP-UIDO ( Site 1202)

Santiago, Region M. de Santiago 7500921

0 studies enrolling now · 2 studies all time

What they study most

Classical Hodgkin Lymphoma, Renal Cell Carcinoma

Studies at this site

• A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). — Running, not enrolling
• Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) — Completed